The Center for Personalized Diagnostics (CPD) is a joint initiative between Penn Medicine's Department of Pathology and Laboratory Medicine and the Abramson Cancer Center to support precision medicine at Penn.
The CPD aims to uncover genetic mutations within a patient's own cancer that can allow for a more targeted and personalized "precision" treatment strategy.
By integrating Molecular Genetics, Pathology Informatics, and Genomic Pathology for precision-medicine diagnoses, the CPD can help physicians provide an appropriate and individualized treatment plan for their patients.
Precision genomic diagnostics can identify patients who might benefit from current, often cutting-edge therapies, while sparing those who do not have a particular genetic signature from the costs and side effects of certain treatments.
Related Links
Published
February 12, 2016
Created by
